pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
raxtozinameran
Comirnaty Omicron XBB.1.5 (raxtozinameran [INN])
Coronavirus Disease 2019 (COVID-19)
$PFEPFIZER INC
0 catalysts
Preclinical
rebastinib
Facioscapulohumeral Muscular Dystrophy (FSHD)
Myocea Inc
0 catalysts
pre_registration
rebisufligene etisparvovec
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
$RAREUltragenyx Pharmaceutical Inc.
0 catalysts
← prev
page 250 of 271
next →
131
Pain89
Neurology1
Phase 3
rebonuputemcel
Degenerative Disc Disease
DiscGenics Inc
0 catalysts
Phase 3
reboxetine
reboxetine [INN]
Type 1 Narcolepsy (Narcolepsy with Cataplexy)
$AXSMAxsome Therapeutics, Inc.
0 catalysts
Preclinical
redaporfin
redaporfin [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Luzitin SA
0 catalysts
Phase 2
refisolone
Salubrin-HF (refisolone)
Premenstrual Dysphoric Disorder (PMDD)
$VTGNVistagen Therapeutics, Inc.
0 catalysts
Phase 2
regdanvimab
regdanvimab [INN]
Coronavirus Disease 2019 (COVID-19)
Celltrion Inc
0 catalysts
Marketed
regorafenib
Stivarga (regorafenib)
Recurrent Glioblastoma Multiforme (GBM)
Discoidin domain-containing receptor 2Ephrin type-A receptor 2
Bayer AG
0 catalysts
Marketed
relacorilant
Lifyorli (relacorilant)
Epithelial Ovarian Cancer
$CORTCORCEPT THERAPEUTICS INC
0 catalysts
Phase 2
relatlimab
Metastatic Hepatocellular Carcinoma (HCC)
Lymphocyte activation gene 3 protein
Bristol-Myers Squibb Co
0 catalysts
pre_registration
relutrigine
relutrigine [INN]
Epileptic Encephalopathy
$PRAXPraxis Precision Medicines, Inc.
0 catalysts
Phase 3
remestemcel-L
Prochymal (remestemcel-L)
Crohn's Disease (Regional Enteritis)
$MESOMESOBLAST LTD
0 catalysts
Phase 2
remetinostat
Cutaneous T-Cell Lymphoma
Biossil Inc
0 catalysts
Marketed
remimazolam besylate
Byfavo (remimazolam besylate)
Sedation
GABA-A receptor; anion channel
Acacia Pharma Group Ltd
0 catalysts
Phase 3
remlifanserin
Alzheimer's Disease
$ACADACADIA PHARMACEUTICALS INC
0 catalysts
Phase 1
remzistotug
Breast Cancer
$GSKGSK plc
0 catalysts
Phase 2
rencofilstat
Hepatocellular Carcinoma
$HEPAHepion Pharmaceuticals, Inc.
0 catalysts
Phase 2
rentosertib acetate
Idiopathic Pulmonary Fibrosis
InSilico Medicine
0 catalysts
Marketed
repaglinide
Repaglinide (repaglinide)
Type 2 Diabetes
Padagis LLC
0 catalysts
Phase 3
repinatrabit
Phenylketonuria (PKU)
Jnana Therapeutics Inc
0 catalysts
Preclinical
repirinast
Chronic Kidney Disease (Chronic Renal Failure)
$AGNPFAlgernon Health Inc.
0 catalysts
Marketed
repotrectinib
Augtyro (repotrectinib)
Non-Small Cell Lung Cancer
NT-3 growth factor receptorBDNF/NT-3 growth factors receptor
Bristol-Myers Squibb Co
0 catalysts
Phase 3
resecabtagene autoleucel
resecabtagene autoleucel [INN]
Juvenile Dermatomyositis
$CABACabaletta Bio, Inc.
0 catalysts
Phase 3
resiniferatoxin
resiniferatoxin [INN]
Osteoarthritis Pain
Grunenthal GmbH
0 catalysts
Phase 2
resiquimod
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Toll-like receptor 7Toll-like receptor 8
SURGE Therapeutics Inc
0 catalysts
Phase 2
resiquimod sulfate
Squamous Non-Small Cell Lung Cancer
$EIKNEikon Therapeutics, Inc.
0 catalysts
Marketed
reslizumab
Cinqair (reslizumab)
Eosinophilic Asthma
Teva Pharmaceuticals USA Inc
0 catalysts
Phase 2
resomelagon acetate
Rheumatoid Arthritis
SynAct Pharma AB
0 catalysts
Phase 2
respiratory syncytial virus vaccine
mRESVIA
Respiratory Syncytial Virus (RSV) Infections
Fusion glycoprotein F0
$MRNAModerna, Inc.
0 catalysts